Babraham Investor Conference (BIC) is a must attend one-day conference for investors focusing on early-stage and scale-up life science and med-tech companies from across the UK and Europe taking place on Wednesday 15th May 2019 at the Babraham Research Campus, Cambridge, UK.
Our programme is currently in development and will feature a rich programme of company presentations and networking opportunities. During the course of the day you can expect:
As Head of Seed Funds at Cambridge Enterprise, Anne has overseen strong growth in our investment activities, with Seed Funds investing over £5 million each year in young companies.
Dr Ian Tomlinson is Chairman of the Board of the Stevenage Bioscience Catalyst, Chairman of the Investment Committee of Apollo Therapeutics and is a member of the Major Awards Committee for the UK governments BioMedical Catalyst funding scheme.
Tamsin has recently taken over as the Director of the Office for Life Sciences, a joint unit part of the Department of Health and Social care and the Department for Business Energy and Industrial Strategy.
Handelsbanken is a full-service bank with a decentralised way of working, a strong local presence due to a nationwide network of over 200 branches and a long-term approach to customer relations.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557